Baystate Health Enrolls First Patients in PIONEER Brain Aneurysm Study

The Silk Vista Baby, manufactured by Balt Corporation, is designed for blood vessels measuring 1.5 to 3 millimeters in diameter. While the device has seen international use for several years, its availability in the U.S. has been limited to a slow humanitarian device exemption process that often required patients to wait up to eight weeks for care. The PIONEER trial, spanning 35 U.S. centers and 5 Canadian sites, aims to provide the clinical data necessary to secure full FDA approval.

Dr. Varun Naragum, director of the Baystate Neuroendovascular Program, noted that the hospital’s selection for the trial reflects its established expertise in treating complex aneurysms. The program, one of the busiest in New England, managed to enroll and treat its first three study participants within days of receiving authorization. Flow diversion works by placing a flexible mesh tube inside a vessel to redirect blood away from the aneurysm, significantly lowering rupture risks. Until the trial concludes and full regulatory approval is granted, access to the device will remain restricted to specialized exemption cases.